Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin

Wang Xuebin , Luo Changqing , Liu Jianshe , Zhang Chun , Wang Yumei , Zhu Zhonghua

Current Medical Science ›› 2005, Vol. 25 ›› Issue (6) : 651 -654.

PDF
Current Medical Science ›› 2005, Vol. 25 ›› Issue (6) : 651 -654. DOI: 10.1007/BF02896161
Article

Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin

Author information +
History +
PDF

Abstract

The expression of serum and glucocorticoid-induced protein kinase in the renal cortex of diabetic rats was examined, and the function of signal transduction mediated by SGK1 in diabetic nephropathy and its modulation by fluvastatin were also investigated. 24 male Wistar rats were randomly divided into normal control group (n=8), diabetic nephropathy group (n=8) and fluvastatin-treated diabetic nephropathy group (15 mg/kg/d,n=8). The metabolic parameters were measured at the 8th week. The expression of transforming growth factorβ1 (TGF-β1) and fibronectin (FN) was immunohistochemically examined. The expression of SGK1 was detected by RT-PCR and Western blot, and CTGF mRNA was assessed by RT-PCR. As compared to DN, blood glucose, 24-h urinary protein, Cer and kidney weight index were all decreased and the weight was increased obviously in group F. At the same time, mesangial cells and extracellular matrix proliferation were relieved significantly. The levels of cortex SGK1 mRNA and protein were up-regulated, and both TGF-β1 and FN were down-regulated by fluvastatin. The mRNA of SGK1 was positively correlated with the CTGF, TGF-β1, and FN. SGK1 expression is markedly up-regulated in the renal cortex of DN group and plays an important role in the development and progress of diabetic nephropathy by means of signal transduction. Fluvastatin suppressed the increased SGK1mRNA expression in renal cortex and postponed the development of diabetic nephropathy.

Keywords

serum and glucocorticoid-inducible kinase / connective tissue growth factor / diabetic nephropathy / fluvastatin

Cite this article

Download citation ▾
Wang Xuebin, Luo Changqing, Liu Jianshe, Zhang Chun, Wang Yumei, Zhu Zhonghua. Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin. Current Medical Science, 2005, 25(6): 651-654 DOI:10.1007/BF02896161

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

LangF, KlingelK, WagnerC A, et al. . Deranged transcriptional regulation of cell volume sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA, 2000, 94: 8157-8157

[2]

WebsterM K, GoyaL, GeY, et al. . Characterization of sgk, anoval member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol, 1993, 13: 2031-2031

[3]

ChS, RushdiS, ZumpeE T, et al. . FSH-regulated gene expression profiles in ovarian tummours and normal ovaries. Mol Hum Rprod, 2002, 8: 426-426

[4]

KumarJ M, BrooksD P, OlsonB A, et al. . Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol, 1999, 10: 2488-2488

[5]

BhargavaA, FullertonM J, MylesK, et al. . The serum-and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology, 2001, 142: 1584-1584

[6]

ReevesW B, AndreoliT E. Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA, 2000, 97: 7667-7667

[7]

VrtovsnikF, EssigM, LimuraO, et al. . Effect of lipid-lowering strategies on tubular cell biology. Kidney Int, 1999, 56: 92-92

[8]

KimS I, KimH J, HanD C, et al. . Effect of lovastatin on small GTP binding proteins and on TGF-β1 and fibronectin expression. Kidney Int, 2000, 58: 88-88

AI Summary AI Mindmap
PDF

84

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/